In AML-mesenchymal stromal cells (MSCs)-CD34+ cells co-cultured system, this a novel COX2/NR4A1/CTNNB1 axis increased leukaemia-reactive T-effector cells and rescued cellular metabolism and anti-leukaemia immunity (95). This evidence concerns the gene PTGS2 and acute myeloid leukemia.